Back to search
FDAFDA · Food and drugs·Recall number D-1285-2022

Aripiprazole Tablets, USP 20 mg, packaged in a) 1,000-count bottle (NDC 60505-2676-8, UPC 3 60505 26768 2), b) 30-count bottle (NDC 60505-2676-3, UPC 3 60505 26763 7), Rx only, Manufactured by: Apotex, Inc. Toronto, Ontario Canada M9L 1T9 Manufactured for: Apotex Corp. Weston, Florida 33326

Published July 27, 2022 · Recall initiated: July 7, 2022

Summary

FDA records drug Class II recall D-1285-2022, published July 27, 2022 and initiated July 7, 2022. Recalling firm: Apotex Corp.; Status: Terminated; Reported quantity: 2010 bottles; Lot: Lots: a) TD9591 Exp. 04/2023; b) TD9592 Exp. 04/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed dissolution specifications: OOS for dissolution at the 12-month stability time point.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Apotex Corp.
Distributor
USA Nationwide
Lot
Lots: a) TD9591 Exp. 04/2023; b) TD9592 Exp. 04/2023
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Aripiprazole Tablets, USP 20 mg, packaged in a) 1,000-count bottle (NDC 60505-2676-8, UPC 3 60505 26768 2), b) 30-count bottle (NDC 60505-2676-3, UPC 3 60505 26763 7), Rx only, Manufactured by: Apotex, Inc. Toronto, Ontario Canada M9L 1T9 Manufactured for: Apotex Corp. Weston, Florida 33326 recalled?

Yes. FDA published recall D-1285-2022 on July 27, 2022. Reported hazard: Failed dissolution specifications: OOS for dissolution at the 12-month stability time point.

What should I do if I have this product?

Voluntary: Firm initiated · Letter